Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Probability of treatment following acute decline in lung function in children with cystic fibrosis is related to baseline pulmonary function.
Morgan WJ, Wagener JS, Yegin A, Pasta DJ, Millar SJ, Konstan MW; Scientific Advisory Group, investigators; coordinators of the Epidemiologic Study of Cystic Fibrosis. Morgan WJ, et al. Among authors: yegin a. J Pediatr. 2013 Oct;163(4):1152-7.e2. doi: 10.1016/j.jpeds.2013.05.013. Epub 2013 Jun 27. J Pediatr. 2013. PMID: 23810128 Free PMC article.
Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis.
Ren CL, Konstan MW, Yegin A, Rasouliyan L, Trzaskoma B, Morgan WJ, Regelmann W; Scientific Advisory Group, Investigators, and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Ren CL, et al. Among authors: yegin a. J Cyst Fibros. 2012 Jul;11(4):293-9. doi: 10.1016/j.jcf.2012.02.005. Epub 2012 Mar 23. J Cyst Fibros. 2012. PMID: 22445849 Free PMC article.
Trends in the use of routine therapies in cystic fibrosis: 1995-2005.
Konstan MW, VanDevanter DR, Rasouliyan L, Pasta DJ, Yegin A, Morgan WJ, Wagener JS; Scientific Advisory Group; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Konstan MW, et al. Among authors: yegin a. Pediatr Pulmonol. 2010 Dec;45(12):1167-72. doi: 10.1002/ppul.21315. Epub 2010 Aug 17. Pediatr Pulmonol. 2010. PMID: 20717935 Free PMC article.
Clinical use of dornase alpha is associated with a slower rate of FEV1 decline in cystic fibrosis.
Konstan MW, Wagener JS, Pasta DJ, Millar SJ, Jacobs JR, Yegin A, Morgan WJ; Scientific Advisory Group and Investigators and Coordinators of Epidemiologic Study of Cystic Fibrosis. Konstan MW, et al. Among authors: yegin a. Pediatr Pulmonol. 2011 Jun;46(6):545-53. doi: 10.1002/ppul.21388. Epub 2011 Mar 24. Pediatr Pulmonol. 2011. PMID: 21438174 Free PMC article.
Risk factors for rate of decline in FEV1 in adults with cystic fibrosis.
Konstan MW, Wagener JS, Vandevanter DR, Pasta DJ, Yegin A, Rasouliyan L, Morgan WJ. Konstan MW, et al. Among authors: yegin a. J Cyst Fibros. 2012 Sep;11(5):405-11. doi: 10.1016/j.jcf.2012.03.009. Epub 2012 May 5. J Cyst Fibros. 2012. PMID: 22561369 Free PMC article.
64 results